Efforts to develop effective therapies for MYC-amplified Group 3 medulloblastoma (G3-MB) are hindered by an incomplete ...
The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a promising way to improve existing cancer therapies ...
Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of 13%. The poor prognosis is due in part both to late detection and the cancer’s capacity to adapt and ...
Oral MYC condensate modulator drives tumor regression and stasis in preclinical modelsDisruption of MYC condensates enables targeted inhibition ...
“MYC amplification is associated with reduced tumor immunogenicity as assessed by the recovery of IR recombination reads from prostate cancer genomics files” Box and whisker plots of selected immune ...
So, what insight are we left with? “On the highest level,” notes Dr. Eisenman, “this study really demonstrates that a single amino acid substitution in a single protein is enough to predispose the ...
Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with ...
Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with each other.
Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with ...
For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, scientists think they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results